01 March 2023: RWW: FDA Guidance on Externally Controlled Trials

01 March 2023: An open discussion on the recently published draft FDA guidance on Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products (https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-design-and-conduct-externally-controlled-trials-drug-and-biological-products).